10-Q: Cross Country Healthcare Reports Q3 Loss Amid Revenue Decline

Cross Country Healthcare reported a significant net loss and revenue decline in Q3 2025, primarily due to volume decreases in staffing segments, while its merger with Aya Healthcare faces delays from a government shutdown.

Summary

• Revenue from services decreased by 20.6% to $250.1 million for the three months ended September 30, 2025, compared to $315.1 million in the prior year.
• The company reported a net loss attributable to common stockholders of $4.8 million for Q3 2025, a significant decline from a net income of $2.6 million in Q3 2024.
• Loss from operations was $6.0 million for Q3 2025, compared to income from operations of $2.9 million in Q3 2024.
• For the nine months ended September 30, 2025, revenue decreased by 20.9% to $817.5 million, and net loss was $11.9 million, compared to a net loss of $10.8 million in the prior year period.
• Cash and cash equivalents stood at $99.1 million as of September 30, 2025.
• Net cash provided by operating activities for the nine months ended September 30, 2025, was $30.0 million, a decrease from $95.9 million in the prior year period.
• The Nurse and Allied Staffing segment's revenue decreased by 23.8% to $202.0 million in Q3 2025, with a 16.8% decline in professionals on assignment.
• The Physician Staffing segment's revenue decreased by 4.3% to $48.1 million in Q3 2025, primarily due to a 15.3% decrease in billable days.
• Acquisition and integration-related costs, primarily for the pending Aya Merger, totaled $4.1 million in Q3 2025 and $12.2 million for the nine months ended September 30, 2025.
• The proposed Aya Merger faces delays due to a U.S. government shutdown, which has extended the HSR waiting period beyond the current December 3, 2025, end date, with discussions ongoing for a further extension.

Sentiment

Score: 3

Explanation: The company reported significant declines in revenue and net income, coupled with substantial merger-related costs and delays in a critical acquisition. While there are some positive sub-segment performances and improved credit loss, the overall financial performance and the uncertainty surrounding the Aya Merger create a negative outlook.

Positives

• Homecare Staffing, a sub-segment of Nurse and Allied Staffing, experienced year-over-year revenue growth of 29.1% and sequential revenue growth of 2.3% for the three months ended September 30, 2025.
• Physician Staffing segment saw an increase in revenue per day filled by 12.9% to $2,324 in Q3 2025, driven by price increases and favorable specialty mix, despite a decline in billable days.
• Credit loss (credit) expense was a credit of $0.9 million for Q3 2025 and $0.8 million for the nine months ended September 30, 2025, indicating improved collections of aged receivables compared to expenses in prior periods.
• The company maintains strong liquidity with $99.1 million in cash and cash equivalents and $103.0 million in available borrowing capacity under its ABL facility as of September 30, 2025, with no borrowings drawn.
• Corporate overhead decreased to $13.7 million in Q3 2025 from $15.5 million in Q3 2024, primarily due to decreases in compensation, benefits, and professional fees.

Negatives

• Consolidated revenue decreased significantly by 20.6% in Q3 2025 and 20.9% for the nine months ended September 30, 2025, primarily due to volume declines in both Nurse and Allied Staffing and Physician Staffing segments.
• The company reported a net loss of $4.8 million in Q3 2025, a substantial deterioration from a net income of $2.6 million in Q3 2024.
• Operating income turned into a loss of $6.0 million in Q3 2025, compared to an operating income of $2.9 million in Q3 2024.
• Net cash provided by operating activities decreased by $65.9 million to $30.0 million for the nine months ended September 30, 2025, compared to $95.9 million in the prior year period.
• Working capital decreased by $5.0 million to $209.6 million as of September 30, 2025, from $214.6 million at December 31, 2024.
• Acquisition and integration-related costs, primarily for the pending Aya Merger, were $4.1 million in Q3 2025 and $12.2 million for the nine months ended September 30, 2025, impacting profitability.
• Restructuring costs increased to $1.5 million in Q3 2025 from $1.0 million in Q3 2024, mainly due to employee termination costs.
• Legal and other losses amounted to $1.1 million in Q3 2025, with no comparable charges in Q3 2024.

Risks

• The timing to consummate the proposed Aya Merger is uncertain, and closing conditions, particularly regulatory approvals from the FTC, may not be satisfied.
• The U.S. government shutdown, which began in October 2025, has delayed the expiry of the Hart-Scott-Rodino (HSR) waiting period for the Aya Merger, pushing it beyond the current December 3, 2025, end date.
• There is no assurance that an agreement to extend the Aya Merger end date beyond December 3, 2025, will be reached between the Company and Aya Healthcare, potentially allowing either party to terminate the Merger Agreement.
• If the Aya Merger is delayed or not completed, the company will incur substantial unrecovered costs, face restrictions on business operations imposed by the Merger Agreement, and may struggle to attract, hire, and retain key employees.
• Failure to complete the Aya Merger could result in management change in control agreements not triggering, potentially leading to key management departures and client losses.
• The company's stock price may decline if the Aya Merger is not completed, as the current market price may reflect an assumption of its completion.
• The overall macroeconomic environment, including increased inflation and interest rates, could adversely affect the company's future results of operations and liquidity.
• Demand for the healthcare services provided by the company, both nationally and regionally, could be uncertain or reduced.
• The ability to attract and retain qualified nurses, physicians, and other healthcare personnel is crucial and subject to market conditions.
• Costs and availability of short-term housing for travel healthcare professionals could impact profitability.
• Cybersecurity risks and incidents could affect the company's business and information systems.
• Existing or future government regulation, federal and state legislative and enforcement initiatives, including data privacy and protection laws, and social, ethical, and security issues relating to artificial intelligence, could impact the business.
• Customers' ability to pay for services could be affected by macroeconomic factors, leading to delays in payments.
• The company faces competition in the markets it serves, which could impact its ability to attract and retain talent and customers.

Future Outlook

The company's future is significantly tied to the consummation of the proposed Aya Merger. While stockholder approval has been received, the merger faces delays due to a U.S. government shutdown impacting FTC review, pushing the HSR waiting period beyond the current December 3, 2025, end date. Discussions are ongoing for a further extension, but there is no assurance of an agreement. If the merger is not completed, the company anticipates incurring substantial unrecovered costs, facing operational restrictions, and potential negative impacts on employee retention and stock price. The company also expects to adopt new FASB accounting standards for income tax disclosures by the end of 2025, expense disaggregation by 2027, and internal-use software accounting by 2028, with immaterial impacts expected on financial condition.

Management Comments

• Management believes that the terms of the related party arrangement for digital marketing services are equivalent to those prevailing in an arm's-length transaction and have been approved by the Audit Committee.
• Management believes that the services provided to entities affiliated with certain Board members were conducted on terms equivalent to those prevailing in an arm's-length transaction.
• Management believes that the outcome of any outstanding loss contingencies, individually or in the aggregate, as of September 30, 2025, will not have a material adverse effect on its business, financial condition, results of operations, or cash flows.

Industry Context

The healthcare staffing industry, particularly for travel nurses and allied professionals, appears to be experiencing volume declines, as evidenced by Cross Country Healthcare's significant revenue decrease in its Nurse and Allied Staffing segment. This could reflect a normalization of demand post-pandemic or broader economic pressures on healthcare providers. Despite overall declines, the growth in Homecare Staffing suggests a shift in demand towards in-home care services, aligning with broader trends of an aging population and preference for care outside traditional hospital settings. The Physician Staffing segment, while also seeing a decline in billable days, managed to increase revenue per day filled, indicating pricing power or a focus on higher-value specialties, potentially reflecting ongoing physician shortages in specific areas.

Comparison to Industry Standards

• NA The filing does not provide specific comparable companies, projects, or results to assess against global benchmarks. The analysis is based solely on the company's internal performance and general industry trends mentioned.

Corporate Governance

Legal Proceedings

• The company is involved in various litigation, claims, investigations, and other proceedings in the ordinary course of business, primarily related to employee-related matters, professional liability, tax, and payroll practices.
• During the third quarter of 2025, the company recorded $1.1 million in legal fees and settlement charges related to various cases and claims.
• The company believes the outcome of any outstanding loss contingencies will not have a material adverse effect on its business, financial condition, results of operations, or cash flows as of September 30, 2025.
• Sales and other state non-income tax filings are subject to routine audits, which may result in assessments of additional taxes, with significant subjectivity in estimation.

Related Party Transactions

• The company has an arrangement for digital marketing services with a firm related to a Board member, who is a minority shareholder and Board member of the firm's parent company. Management believes terms are arm's-length and approved by the Audit Committee; expenses were immaterial.
• The company provides services to entities affiliated with certain Board members. Revenue from these transactions was $2.2 million for Q3 2025 and $6.7 million for the nine months ended September 30, 2025. Management believes terms were arm's-length.

Stakeholder Impact

• Shareholders: Face significant uncertainty regarding the Aya Merger, potential stock price volatility if the merger fails, and a substantial decline in profitability (net loss of $4.8M in Q3 2025).
• Employees: Potential impact on key employee retention if the Aya Merger is delayed or terminated, as change-in-control agreements may not trigger. Restructuring costs indicate ongoing employee termination activities.
• Customers: Volume declines in staffing segments suggest reduced demand or increased competition, potentially impacting service availability or pricing for customers. Delays in the merger could affect customer relationships.
• Suppliers: Potential impact on relationships if the merger is delayed or terminated.
• Creditors: The company maintains strong liquidity with no ABL borrowings and significant availability, suggesting a stable position for creditors despite operational losses.

Next Steps

• Continue discussions with Aya Healthcare regarding an extension of the Aya Merger end date beyond December 3, 2025.
• Monitor the U.S. government shutdown's impact on the FTC's review of the Aya Merger and the HSR waiting period expiry.
• Prepare for the 2025 Annual Meeting of Stockholders on December 9, 2025, if the Aya Merger is not completed prior to that date.
• Take possession of the new corporate headquarters in Boca Raton, Florida, on December 1, 2025.
• Adopt new FASB accounting standards for income tax disclosures for the annual report for the fiscal year ended December 31, 2025.
• Adopt new FASB accounting standards for income statement expense disaggregation for the annual report for the fiscal year ending December 31, 2027.
• Adopt new FASB accounting standards for internal-use software accounting for the first quarter ending March 31, 2028.

Key Dates

Recommendation

The company reported a substantial decline in revenue and a shift to a net loss in Q3 2025, indicating significant operational challenges. The proposed Aya Merger, a key strategic event, faces material delays due to a government shutdown, introducing considerable uncertainty and the risk of termination. If the merger fails, the company will incur unrecovered costs, face operational restrictions, and likely experience a significant negative impact on its stock price and ability to retain key personnel. While some sub-segments show growth and liquidity remains adequate, the overall negative financial performance, coupled with the high-stakes merger uncertainty and associated risks, suggests a 'sell' recommendation for investors seeking to mitigate exposure to these immediate headwinds and potential downside.

Keywords

Healthcare Staffing, Temporary Staffing, Nurse Staffing, Physician Staffing, Aya Merger, SEC Filing, 10-Q, Financial Results, Q3 2025, Government Shutdown, Merger Delay, Healthcare Industry, Travel Nurse, Allied Health, Workforce Solutions